MUC1 and COVID-19: Both methods proved reliable and comparable for detecting KL‐6 in serum from hospitalized COVID‐19 and post‐COVID‐19 patients (2–5 months after discharge from hospital), highlighting the role of this protein in identifying fibrotic lung damage [15].